Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Musette

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Medicine|December 20, 2017
New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms PathophysiologyPhilippe Musette, Baptiste Janela
Frontiers in Immunology|May 1, 2018
B Cell Modulation Strategies in Autoimmune Diseases: New ConceptsPhilippe Musette, Jean David Bouaziz
Immunotherapy|October 13, 2020
Clinical and biological activity of rituximab in the treatment of pemphigusGérôme Bohelay, Frédéric Caux, Philippe Musette
Medecine Sciences : M/S|February 7, 2006
[Innate immunity: cutaneous expression of Toll-like receptors]Philippe Musette, Isabelle Auquit Auckbur, Edouard Begon
Immunobiology|February 5, 2008
Toll-like receptor 9 in murine lupus: more friend than foe!Philipp Yu, Philippe Musette, Stanford L Peng
Current Opinion in Immunology|October 16, 2012
Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesisXavier Camous, Sebastien Calbo, Damien Picard, et al.
Blood|July 20, 2002
Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signalingMaria Nikolova, Philippe Musette, Martine Bagot, et al.
Frontiers in Molecular Biosciences|February 21, 2022
Autoimmune Pemphigus: Latest Advances and Emerging TherapiesYen Loo Lim, Gerome Bohelay, Sho Hanakawa, et al.
Annales De Pathologie|March 2, 2005
[Clear cell dermatofibroma: a case report with cytogenetic study]Céline Riopel, Philippe Musette, Corinne Bodenant, et al.
Critical Care Medicine|March 28, 2009
Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in miceYgal Benhamou, Julie Favre, Philippe Musette, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Medicine|December 20, 2017
New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms PathophysiologyPhilippe Musette, Baptiste Janela
Frontiers in Immunology|May 1, 2018
B Cell Modulation Strategies in Autoimmune Diseases: New ConceptsPhilippe Musette, Jean David Bouaziz
Immunotherapy|October 13, 2020
Clinical and biological activity of rituximab in the treatment of pemphigusGérôme Bohelay, Frédéric Caux, Philippe Musette
Medecine Sciences : M/S|February 7, 2006
[Innate immunity: cutaneous expression of Toll-like receptors]Philippe Musette, Isabelle Auquit Auckbur, Edouard Begon
Immunobiology|February 5, 2008
Toll-like receptor 9 in murine lupus: more friend than foe!Philipp Yu, Philippe Musette, Stanford L Peng
Current Opinion in Immunology|October 16, 2012
Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesisXavier Camous, Sebastien Calbo, Damien Picard, et al.
Blood|July 20, 2002
Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signalingMaria Nikolova, Philippe Musette, Martine Bagot, et al.
Frontiers in Molecular Biosciences|February 21, 2022
Autoimmune Pemphigus: Latest Advances and Emerging TherapiesYen Loo Lim, Gerome Bohelay, Sho Hanakawa, et al.
Annales De Pathologie|March 2, 2005
[Clear cell dermatofibroma: a case report with cytogenetic study]Céline Riopel, Philippe Musette, Corinne Bodenant, et al.
Critical Care Medicine|March 28, 2009
Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in miceYgal Benhamou, Julie Favre, Philippe Musette, et al.
Pageof 5